Sage Therapeutics Inc (SAGE)
4.85
-0.06
(-1.22%)
USD |
NASDAQ |
Nov 21, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Enterprise Value: -268.79M for Nov. 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2024 | -268.79M |
| November 19, 2024 | -268.79M |
| November 18, 2024 | -276.75M |
| November 15, 2024 | -257.17M |
| November 14, 2024 | -240.65M |
| November 13, 2024 | -218.63M |
| November 12, 2024 | -218.63M |
| November 11, 2024 | -183.76M |
| November 08, 2024 | -183.15M |
| November 07, 2024 | -182.54M |
| November 06, 2024 | -205.17M |
| November 05, 2024 | -205.78M |
| November 04, 2024 | -213.74M |
| November 01, 2024 | -199.06M |
| October 31, 2024 | -197.22M |
| October 30, 2024 | -175.20M |
| October 29, 2024 | -50.40M |
| October 28, 2024 | -46.73M |
| October 25, 2024 | -79.16M |
| October 24, 2024 | -88.94M |
| October 23, 2024 | -101.18M |
| October 22, 2024 | -101.18M |
| October 21, 2024 | -92.61M |
| October 18, 2024 | -106.07M |
| October 17, 2024 | -128.09M |
| Date | Value |
|---|---|
| October 16, 2024 | -124.42M |
| October 15, 2024 | -149.51M |
| October 14, 2024 | -152.56M |
| October 11, 2024 | -166.02M |
| October 10, 2024 | -179.48M |
| October 09, 2024 | -172.14M |
| October 08, 2024 | -175.81M |
| October 07, 2024 | -158.07M |
| October 04, 2024 | -162.96M |
| October 03, 2024 | -141.55M |
| October 02, 2024 | -142.16M |
| October 01, 2024 | -143.39M |
| September 30, 2024 | -127.48M |
| September 27, 2024 | -201.74M |
| September 26, 2024 | -209.06M |
| September 25, 2024 | -218.22M |
| September 24, 2024 | -200.51M |
| September 23, 2024 | -205.40M |
| September 20, 2024 | -188.92M |
| September 19, 2024 | -164.49M |
| September 18, 2024 | -183.42M |
| September 17, 2024 | -187.69M |
| September 16, 2024 | -184.64M |
| September 13, 2024 | -168.77M |
| September 12, 2024 | -197.46M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-276.75M
Minimum
Nov 18 2024
6.898B
Maximum
Nov 29 2019
1.147B
Average
826.50M
Median
Enterprise Value Benchmarks
| Outset Medical Inc | 59.68M |
| Biogen Inc | 27.33B |
| Johnson & Johnson | 384.09B |
| Lifecore Biomedical Inc | 397.87M |
| Organon & Co | 11.78B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -93.55M |
| Revenue (Quarterly) | 11.87M |
| Total Expenses (Quarterly) | 113.07M |
| EPS Diluted (Quarterly) | -1.53 |
| Gross Profit Margin (Quarterly) | 55.54% |
| Profit Margin (Quarterly) | -788.1% |
| Earnings Yield | -114.8% |
| Normalized Earnings Yield | -114.92 |